2013
DOI: 10.1371/journal.ppat.1003642
|View full text |Cite
|
Sign up to set email alerts
|

Are We There Yet? Recent Progress in the Molecular Diagnosis and Novel Antifungal Targeting of Aspergillus fumigatus and Invasive Aspergillosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
27
0

Year Published

2014
2014
2022
2022

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 27 publications
(27 citation statements)
references
References 20 publications
0
27
0
Order By: Relevance
“…Invasive aspergillosis (IA) is one of the major detrimental fungal infections in immunocompromised patients, and A. fumigatus causes approximately 90% of IA cases (Denning, ). Despite the increasing number of immunocompromised individuals, the current options for IA diagnosis and treatment are limited (Denning, ; Perfect, ; Steinbach, ). To improve patient outcomes, more information on fungal adaptations to host environments is needed.…”
Section: Introductionmentioning
confidence: 99%
“…Invasive aspergillosis (IA) is one of the major detrimental fungal infections in immunocompromised patients, and A. fumigatus causes approximately 90% of IA cases (Denning, ). Despite the increasing number of immunocompromised individuals, the current options for IA diagnosis and treatment are limited (Denning, ; Perfect, ; Steinbach, ). To improve patient outcomes, more information on fungal adaptations to host environments is needed.…”
Section: Introductionmentioning
confidence: 99%
“…To prevent severe disease caused by Aspergillus spp., early diagnosis and suitable antifungal treatments are required. However, timely and accurate diagnosis remains a challenge and clinical use of antifungal drugs is difficult due to host toxicity and emerging antifungal drug resistance (Steinbach, 2013).…”
Section: Introductionmentioning
confidence: 99%
“…4 While therapeutic strides have been made against Aspergillus in the last decade, advances in medical treatment of many cancers and autoimmune diseases continue to increase the patient population at risk for life threatening Aspergillus infections. 5 While epidemiological data on A. fumigatus infections remains enigmatic, recent estimates and clinical experience strongly suggest the incidence of disease is far greater than previously appreciated. [6][7][8] Perhaps most importantly, regardless of disease incidence, the recalcitrant nature of Aspergillus infections to medical intervention too often leads to poor treatment outcomes.…”
mentioning
confidence: 99%
“…[6][7][8] Perhaps most importantly, regardless of disease incidence, the recalcitrant nature of Aspergillus infections to medical intervention too often leads to poor treatment outcomes. 5,9 Many reasons explain the unacceptably high treatment failures with Aspergillus infection. For one, as a fellow eukaryote, survival and proliferation of A. fumigatus relies on fundamental pathways of nutrient acquisition and utilization similar to those used by humans.…”
mentioning
confidence: 99%
See 1 more Smart Citation